Aviso: para depositar documentos, por favor, inicia sesión e identifícate con tu cuenta de correo institucional de la UCM con el botón MI CUENTA UCM. No emplees la opción AUTENTICACIÓN CON CONTRASEÑA
 

Bispecific Antibody Format and the Organization of Immunological Synapses in T Cell-Redirecting Strategies for Cancer Immunotherapy

dc.contributor.authorCarrasco Padilla, Carlos
dc.contributor.authorHernaiz Esteban, Alicia
dc.contributor.authorÁlvarez Vallina, Luis
dc.contributor.authorAguilar Sopeña, Óscar
dc.contributor.authorRoda Navarro, Pedro
dc.date.accessioned2023-06-22T11:20:46Z
dc.date.available2023-06-22T11:20:46Z
dc.date.issued2022-12-30
dc.description.abstractT cell-redirecting strategies have emerged as effective cancer immunotherapy approaches. Bispecific antibodies (bsAbs) are designed to specifically recruit T cells to the tumor microenvironment and induce the assembly of the immunological synapse (IS) between T cells and cancer cells or antigen-presenting cells. The way that the quality of the IS might predict the effectiveness of T cell-redirecting strategies, including those mediated by bsAbs or by chimeric antigen receptors (CAR)-T cells, is currently under discussion. Here we review the organization of the canonical IS assembled during natural antigenic stimulation through the T cell receptor (TCR) and to what extent different bsAbs induce T cell activation, canonical IS organization, and effector function. Then, we discuss how the biochemical parameters of different formats of bsAbs affect the effectivity of generating an antigen-induced canonical IS. Finally, the quality of the IS assembled by bsAbs and monoclonal antibodies or CAR-T cells are compared, and strategies to improve bsAb-mediated T cell-redirecting strategies are discussed.
dc.description.departmentDepto. de Inmunología, Oftalmología y ORL
dc.description.facultyFac. de Medicina
dc.description.refereedTRUE
dc.description.sponsorshipMinisterio de Ciencia e Innovación (España)
dc.description.sponsorshipInstituto de Salud Carlos III
dc.description.sponsorshipFundación CRIS del Cáncer
dc.description.sponsorshipAsociación Española Contra el Cáncer
dc.description.sponsorshipFundación “La Caixa”
dc.description.sponsorshipFundación de Investigación Biomédica 12 de Octubre
dc.description.statuspub
dc.eprint.idhttps://eprints.ucm.es/id/eprint/78428
dc.identifier.doi10.3390/pharmaceutics15010132
dc.identifier.issn1999-4923
dc.identifier.officialurlhttps://doi.org/10.3390/pharmaceutics15010132
dc.identifier.relatedurlhttps://www.mdpi.com/journal/pharmaceutics
dc.identifier.urihttps://hdl.handle.net/20.500.14352/72336
dc.issue.number1
dc.journal.titlePharmaceutics
dc.language.isoeng
dc.page.initial132
dc.publisherMDPI
dc.relation.projectIDPID2020-115444GB-I00 ; PID2020-117323RB-100 y PDC2021-121711-100
dc.relation.projectIDDTS20/00089
dc.relation.projectIDFCRIS-2021-0090
dc.relation.projectIDPROYE19084ALVA
dc.relation.projectIDHR21-00761 IL7R_LungCan
dc.relation.projectIDPrograma Investiga (2022-0082)
dc.rightsAtribución 3.0 España
dc.rights.accessRightsopen access
dc.rights.urihttps://creativecommons.org/licenses/by/3.0/es/
dc.subject.cdu612.017
dc.subject.cdu616-006.04
dc.subject.keywordIS
dc.subject.keywordT cell
dc.subject.keywordImmunotherapy
dc.subject.keywordbsAb
dc.subject.keywordCAR
dc.subject.keywordTCR
dc.subject.ucmMedicina
dc.subject.ucmInmunología
dc.subject.ucmOncología
dc.subject.unesco32 Ciencias Médicas
dc.subject.unesco2412 Inmunología
dc.subject.unesco3201.01 Oncología
dc.titleBispecific Antibody Format and the Organization of Immunological Synapses in T Cell-Redirecting Strategies for Cancer Immunotherapy
dc.typejournal article
dc.volume.number15
dspace.entity.typePublication
relation.isAuthorOfPublication395f5345-8bac-41a2-a014-53c44bf97360
relation.isAuthorOfPublication.latestForDiscovery395f5345-8bac-41a2-a014-53c44bf97360

Download

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
pharmaceutics-15-00132.pdf
Size:
894.36 KB
Format:
Adobe Portable Document Format

Collections